Home > National Drug Code (NDC) > Depo-SubQ Provera

Depo-SubQ Provera - 0009-4709-13 - (medroxyprogesterone acetate)

Alphabetical Index


Drug Information of Depo-SubQ Provera

Product NDC: 0009-4709
Proprietary Name: Depo-SubQ Provera
Non Proprietary Name: medroxyprogesterone acetate
Active Ingredient(s): 104    mg/.65mL & nbsp;   medroxyprogesterone acetate
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of Depo-SubQ Provera

Product NDC: 0009-4709
Labeler Name: Pharmacia and Upjohn Company
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021583
Marketing Category: NDA
Start Marketing Date: 20050502

Package Information of Depo-SubQ Provera

Package NDC: 0009-4709-13
Package Description: .65 mL in 1 SYRINGE (0009-4709-13)

NDC Information of Depo-SubQ Provera

NDC Code 0009-4709-13
Proprietary Name Depo-SubQ Provera
Package Description .65 mL in 1 SYRINGE (0009-4709-13)
Product NDC 0009-4709
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name medroxyprogesterone acetate
Dosage Form Name INJECTION, SUSPENSION
Route Name SUBCUTANEOUS
Start Marketing Date 20050502
Marketing Category Name NDA
Labeler Name Pharmacia and Upjohn Company
Substance Name MEDROXYPROGESTERONE ACETATE
Strength Number 104
Strength Unit mg/.65mL
Pharmaceutical Classes Progesterone Congeners [Chemical/Ingredient],Progestin [EPC]

Complete Information of Depo-SubQ Provera


General Information